These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 24041675)

  • 21. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between lower urinary tract symptoms, the bother they induce and erectile dysfunction.
    Ströberg P; Boman H; Gellerstedt M; Hedelin H
    Scand J Urol Nephrol; 2006; 40(4):307-12. PubMed ID: 16916772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
    Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
    J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Doğan Y; Uruç F; Aras B; Şahin A; Kıvrak M; Ürkmez A; Güner ND; Aydın S
    Turk J Urol; 2015 Mar; 41(1):7-12. PubMed ID: 26328190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome.
    Demir O; Akgul K; Akar Z; Cakmak O; Ozdemir I; Bolukbasi A; Can E; Gumus BH
    Aging Male; 2009 Mar; 12(1):29-34. PubMed ID: 19326294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC; Rosenberg M; Kissel J; Wong DG
    Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction.
    Broderick GA; Brock GB; Roehrborn CG; Watts SD; Elion-Mboussa A; Viktrup L
    Urology; 2010 Jun; 75(6):1452-8. PubMed ID: 20163842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between lower urinary tract symptoms and erectile dysfunction.
    Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
    Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening.
    Reggio E; de Bessa J; Junqueira RG; Timm O; Sette MJ; Sansana V; Gomes CM
    Int J Impot Res; 2007; 19(5):492-5. PubMed ID: 17554395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.
    Lee YC; Wu WJ; Liu CC; Wang CJ; Li WM; Huang CH; Yeh HC; Ke HL; Huang SP
    J Sex Med; 2009 Nov; 6(11):3158-65. PubMed ID: 19515207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influences of erectile functions in benign prostatic hyperplasia patients by two micro (thulium) laser resection of prostate-tangerine technique].
    Luo GH; Sun ZL; Xia SJ
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(32):2243-6. PubMed ID: 22094087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2016 Dec; 70(6):449-452. PubMed ID: 28210019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies.
    Porst H; Oelke M; Goldfischer ER; Cox D; Watts S; Dey D; Viktrup L
    Urology; 2013 Sep; 82(3):667-73. PubMed ID: 23876588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.
    Ozayar A; Zumrutbas AE; Yaman O
    Int Urol Nephrol; 2008; 40(4):933-9. PubMed ID: 18437522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The positive effect of sildenafil on LUTS from BPH while treating ED].
    Ying J; Yao D; Jiang Y; Ren X; Xu M
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.